** Shares of Trajan Group Holdings TRJ.AX rise 11.5% to A$0.925, eyeing their best trading session since mid-May 2024
** Stock hits highest since February 6
** Life sciences co logs 1H25 adjusted EBITDA of A$7.9 mln ($4.97 mln) vs A$4 mln during the same period last year
** Attributes earnings growth to strong distribution from its capital equipment segment
** Also reaffirms net revenue guidance of A$160 mln-A$165 mln for fiscal 2025 vs A$155 mln in FY24
** More than 66,000 shares change hands, 3.6 times the 30-day avg
** Traja down 18.1% YTD, including current session's moves
($1 = 1.5908 Australian dollars)
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。